Orphan Drugs and Rare Diseases Global Congress 2020 Europe

This conference brings together stakeholders in the orphan drugs industry to discuss and network with top tier government, pharmaceuticals, biotechs, non-profit organisations, orphan drug developers, research organisations as well as patients groups and advocates.

Dr Jonathan Appleby, Chief Scientific Officer

Chairing keynote panel discussion

Cell and Gene Therapies for Rare Diseases: Solutions for realising the potential of the next generation of medicine

11.15-12.00, Tuesday 20th October 2020

Find out more and register here

Discover who we are